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Abstract
Genetic manipulation of mammalian cells provides a foundation for contemporary
biological research both basic and applied. Existing methods for construction and
introduction of large scale exogenous genetic information into mammalian cells and for
creating stable cell lines are not efficient and suffer from limitations in terms of cost, speed,
flexibility, and reliability.
In this thesis, a novel method is presented for the efficient construction and delivery of
complex genetic circuits into mammalian cells. Multi-gene circuits are assembled with
high efficiency from a validated modular library into single pieces. The assembled circuits
can be used for transient expression and each individual circuit can be integrated into a
cellular genome to create a stable cell line.
Genetic circuits were constructed that contain several expression units, including inducible
control units and fluorescent markers. These circuits were delivered into Human
Embryonic Kidney 293 (HEK293) cells for both transient and stable expression cases.
Results show that the introduced genetic circuits performed as designed and that stable cell
lines, each with the desired phenotype could be created efficiently. Several factors
affecting the assembly efficiency and the performance of resulting circuits are also
discussed.
Thesis Supervisor: Ron Weiss
Title: Associate Professor
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Chapter 1
1. Introduction
Genetic manipulation of mammalian cells is a fundamental tool in basic and applied
biological research. The mammalian cell can be thought of as a machine being run by a
regulatory network of genes. A gene regulatory network is a collection of DNA segments
(genes) that interact with each other (through their RNA and protein products) and with
proteins in the cell, thereby governing the rates at which genes in the network are
transcribed into mRNAs. These mRNAs encode proteins that fulfill cellular functions,
including growth and division, signaling, regulation, and differentiation[1], [2]. Genetic
circuits are subsets of larger gene regulatory networks consisting of functional clusters of
genes that can modulate each other's expression through regulatory elements [3].
From the point of view of biologists, custom-building genetic circuits and testing them in
living cells provides an unique opportunity to observe the behavior of biological
components in different contexts, reveals the extent of our understanding of natural
systems, and provides new insights in genetic control and molecular dynamics. One
notable example was recent discoveries of stem cell differentiation pathways. Expression
of certain stem cell-associated genes in fibroblasts can transform the cells to the pluripotent
state [4], [5]. Similar studies have shown that fibroblast cells and stem cells can be
reprogrammed into, for instance, pan-neurons [6], [7] or specific neuronal subtypes by
ectopic gene expression [8], [9]. Work by Aviv [10] demonstrated that the hematopoietic
cell differentiation process can be precisely controlled by exploiting one of the network
motif regulators. In all of these experiments, master regulators governing cell
differentiation circuitry were selected and perturbed, demonstrating the importance of
genetic manipulation at the gene circuit level in answering basic biology questions.
For bioengineers, the emerging discipline of synthetic biology aims to rewire and
reprogram organisms with novel phenotypes by assembling molecular "parts" (such as
genetic elements) into biological "devices" (genetic circuits) that exhibit predictable
behavior [11-13]. Applications include microbial production of chemical precursors, novel
antibiotics and biofuels, and creation of synthetic attenuated viruses for use as vaccines
[14], [15]. Synthetic biology also offers an alternative bottom-up approach to
understanding biological networks and disease mechanisms, based on designing and
constructing simple synthetic gene circuits [16]. Over the last decade, synthetic approaches
have provided key insights into the principles of gene circuit design [17-22]. To date,
however, advances in synthetic biology are largely represented by synthetic bacterial
systems [11], [20], [23], while eukaryotic synthetic biology efforts, especially in
mammalian cells, are lagging behind, despite their indispensable potential value in
gene-function analysis, drug discovery, the pharmaceutical manufacturing of protein
therapeutics, and the implementation of gene-based therapies [12], [24-29]. As synthetic
biology moves towards introducing more complex synthetic system into mammalian cells,
tools, similar to the mature techniques employed in Escherichia coli (E. coli) genetics,
have to be developed to facilitate the manipulation of mammalian genetic systems [11]. An
essential element is the ability to physically design, construct and deliver complex genetic
circuits which contain large numbers of expression units with regulatory elements.
1.1. Thesis Statement
In this thesis, we present a system to rapidly construct and deliver large mammalian genetic
circuits. Firstly, Gateway recombination is employed to generate expression units out of
mammalian genetic parts. Then a Gibson-based method is applied to rapidly assemble a
genetic circuit consisting of these units. The assembly process can be easily automated,
allowing the construction of a scalable circuit comprising many parts without human
intervention. The assembled genetic circuit is then ready to be introduced into mammalian
cells using a delivery method compatible with a carrier vector chosen. The achievement of
this capability has the potential to greatly advance experimental mammalian genetics, and
promote biological investigation as well as the synthetic engineering effort.
1.2. Previous Work
Current approaches to design, construct and deliver complex genetic circuits share one or
more disadvantages, which are summarized in the following sections.
1.2.1. Genetic Circuit Design and Construction Methods
First of all, we want to introduce the metrics, shown in Table 1-1 with which we evaluate
methods for genetic circuit design and construction.
Depending on the application, a genetic circuit could be a simple vector for constitutive
co-expression of genes, or a circuitry with complex regulatory interaction. Circuit design
and construction methods should be driven to accommodate different practical needs. Once
a circuit is designed, it needs to be constructed. In most cases it is difficult to directly
synthesize the entire circuit as the cost associated with synthesis of a large construct is still
prohibitive. The usual technique is to start with DNA molecules that contain sequences of
interest. Then recombinant DNA technique is used to combine those pieces of desired
sequences. This often involves physical transfer of genetic materials, e.g. a promoter being
cloned from the original plasmid into a new circuit, with the potential for introducing DNA
mutations. Mutations could make a circuit different from the desired. Therefore,
construction fidelity is critical.
Modular design, using a verified library of parts, is a good way to ensure fidelity, reuse
existing materials, standardize construction and minimize construction steps.
Scalability is another important metric. As we design more complex gene circuits, two
pertinent questions are: Does the method provide the ability to build the circuit? Does the
method allow us to add new parts to existing functional circuits? Employing scalable
methods will yield good solutions to both. It is important to point out that mammalian gene
expression is not as simple as that in E. coli. For a circuit to be persistently functional,
chromatin modulating elements and other important genetic elements should be taken into
account at the design step.
Metric Explanation
1 Design Flexibility Independent expression regulation; Complex regulatory gene circuit
2 Construction Fidelity Mutation free construction
3 Modularity Library based method; Reuse of existing materials
4 Scalability Construction of larger gene circuit
5 Ease of construction Simple protocol
6 Expression Reliability Gene expression as designed
Table 1-1: Metrics for evaluating genetic circuit design and construction methods
1.2.1.1. Gene Circuit Design
A basic part of a gene circuit is the promoter-gene pair or expression unit. In mammalian
cells, transcription machinery binds the promoter and transcribes a gene into an mRNA,
which is then translated to a protein. Similarly, microRNA can be transcribed, and
processed for RNA interference.
A direct extension of a single promoter-gene pair to a multi-gene circuit is the
concatenation of genes together under the same promoter to form a polycistronic construct.
These genes are transcribed from a single promoter, but the mRNA product is then
translated into separate products. IRES and 2A sequences serve this purpose [30], [31].
Internal ribosome entry site (IRES) sequences are able to associate with ribosomes in the
middle of an mRNA and to initiate translation of the downstream gene. Co-expression of
genes can be done using IRES, however the expression levels of the genes upstream and
downstream of IRES are highly correlated and the genes placed downstream are expressed
at a much lower level [30], [32], [33]. The 2A sequence, first found in the foot-and-mouth
disease virus (FMDV), encodes a short polypeptide that mediates self-cleavage by a
translational effect [31]. Ribosome-procession-arrest leads to release of the nascent
polypeptide and re-initiation of translation at the next in-frame codon (ribosome skipping).
In this way, discrete protein products are derived from a single promoter. Problems arises
in both approaches as they do not have transcriptional regulation over individual
downstream genes, thus the polycistronic method does not meet our needs for design
flexibility in building complex gene circuits.
A complex genetic circuit that has multiple expression units can be designed onto several
vectors instead, with each vector carrying one promoter-gene pair. Vectors can be
co-transfected into cells for transient or stable expression, however, the stochastic
stoichiometry of transfected vectors may lead to failure of the entire circuit because of a
possible input-output mismatching between units [13]. The problem becomes even more
severe when a large number of vectors need to be co-transfected for a large circuit. In
addition, it is difficult to select the cells containing the entire genetic circuit due to the
limited number of selection markers [34]. Alternatively, here we assemble multiple
promoter-gene pairs into a single large vector. The genetic circuit on a large vector can be
transiently transfected into cells or stably integrated in the chromosome. Only one
selection marker is necessary for selecting a stable cell line baring the multi-gene
construct.
1.2.1.2. Gene Circuit Construction Methods
In this section, we discuss common methods for assembly of multi-gene constructs.
Restriction Enzyme-based Cloning Methods
Promoters, genes, or parts are initially stored on separated vectors and can be joined to
form a gene circuit through a cloning process using restriction endonuclease (RE). RE are
enzymes that can cleave DNA molecules only when specific DNA sequences are
encountered, called restriction sites (RS). A cloning vector is treated with an RE to cleave
the DNA at the site where a new genetic part will be inserted. The genetic part to be
inserted can be amplified via a polymerase chain reaction (PCR) (an error-prone step) with
a compatible restriction site added on both ends. It is then treated with a restriction
endonuclease to generate ends compatible to those on the vector. The creation of the
assembled DNA is a simple process where digested vector and insert are mixed at
appropriate concentrations and exposed to a DNA ligase that covalently links the ends in a
process called ligation. Ligation usually results in a DNA mixture containing randomly
joined ends, out of which the desired product should be selected [35]. Restriction enzyme
based cloning can be used for assembly of multi-gene circuits, such as biobricks [36],
where DNA parts are modularized by removing certain RS inside and framing with those
RSs. However, several rounds of PCR, restriction enzyme digestion, and ligation processes
may be needed to build the full circuit, making it a time consuming and error-prone method.
Besides, REs that are usually 6bp in length are frequently present in mammalian genetic
sequences e.g. promoter, gene in many copies, thereby limiting its use for construction of
complex mammalian gene circuits.
Type IIS Restriction Enzyme-based Cloning Methods
This cloning method is based on the special ability of type IIS restriction enzymes to cleave
outside of their recognition sequence. Since actual cut sites are outside of the IIS restriction
recognition site, the cut sites can be designed to create different overhangs so that ligation
of multiple fragments in a single step feasible. Intermediate ligated products still contain
restriction sites and should be digested until ligated properly. Examples using this method
include Golden Gate cloning, and MoClo [37], [38]. Usually, restriction enzymes like BsaI
and BsmBI that can create 4bp overhang are used to maximize the number of possible
distinct overhangs. The disadvantage of this method is that it relies on enzymes that usually
only have 6bp recognition sequences. As discussed in the previous section, it poses a
difficulty for its application in mammalian gene circuit construction. In addition, it has
been shown that ligation with 4bp overhangs is vulnerable to mismatching, and, therefore,
the cloning efficiency decreases significantly when the number of input fragments
increases[39].
Recombinase-based Cloning Methods
Recombinase-based cloning methods are easy to use and highly efficient as compared to
restriction-ligation methods. These technologies take advantages of bacterial or viral
site-specific recombinases such as phage X integrase, phage P1 Cre, or yeast recombinase
FLP [40], [41]. Recombinases catalyze a double-stranded DNA exchange between two
specific DNA sequences called recombination sites. Gateway (Invitrogen) is one of the
most popular recombination cloning method and is based on the site-specific
recombination reactions of bacteriophage lambda in E. coli [42]. The recombination
reactions can be represented as follows:
attBi x attPi <-+ attLi x attRi (i E n n is the number of orthogonal recombination sites)
The attBi x attPi reaction (BP reaction) is mediated by proteins Int and IHF.
The attLi x attRi reaction (LR reaction) is mediated by proteins Int, IHF, and Xis.
Only recombination sites belonging to the same set (same i, B to P, R to L) can be
recombined [43]. Several mutations have been introduced into att sites to make the LR
reaction irreversible and to optimize reaction specificity and efficiency. The genetic
element of interest can be PCR amplified with attBi sites on the ends and inserted into a
cloning vector carrying attPi (donor vector) in a BP reaction. The reaction products are a
byproduct and a vector (entry vector) bearing the genetic part of interest flanked by
attLi/attRi sites (crossover of attBi and attPi sites). This process can be easily extended to
create a library of entry vectors. Entry vectors are sequencing verified and can be used in
LR reactions for the assembly of gene circuits in a modular fashion with high fidelity and
efficiency. Nevertheless, the commercial Gateway system only allows 4-way multisite
gateway recombination, which greatly limits the complexity of the circuits that can be built.
A time-consuming system has been proposed to assemble gene circuits hierarchically by
alternating negative selections in successive rounds [44].
Another approach exploits Cre-mediated recombination [45] using a Cre/LoxP-based
strategy, where each circuit-component contains a LoxP site and a distinct selection marker.
Components are fused into one single vector by recombining their LoxP site in the
presence of Cre. The desired product is selected by a combination of bacterial antibiotics
and a strain-specific origin of replication. The maximum number of promoter-gene pairs is
limited to 5, the number of available prokaryotic antibiotics.
In Fusion cloning method
Another method, In Fusion, use a patented enzyme to catalyze DNA ligation [46]. The 3'
and 5' regions of the homolog called extension are added onto the ends of inputs. The
enzyme joins the ends of linear inputs that share the same extension. When linear inputs are
combined, the In-Fusion enzymes recess the double-stranded extension into
single-stranded DNA overhangs and fuse those regions to their complementary ends. In
Fusion requires PCR [47] that makes In Fusion method susceptible to mutations. Besides,
this method is not scalable in practice because of its high cost.
Gibson Method
Daniel Gibson described an enzymatic reaction mix composed of exonuclease, polymerase,
and ligase [48]. In this reaction, the exonuclease first chews back DNA to expose long
overhangs, and then compatible overhangs are annealed. Over-exposed regions are filled in
by a polymerase and joints are repaired by a ligase. All these enzymatic reactions can be
carried out in a single isothermal step in an optimized reaction buffer [49]. This enzyme
mix was used to assemble DNA molecule as large as 900kb in vitro. However, the method
requires PCR or chemically synthesized products as inputs which are either error prone or
expensive. Restriction digested fragments can also be used, but just like other restriction
enzyme based methods, this is not applicable to mammalian gene circuit assembly.
1.2.2. Delivery Methods
This section discusses current methods for introducing genetic circuits into mammalian
cells.
1.2.2.1. Transient Transfection
Assembled circuits can be delivered into mammalian cells using chemical-based
transfection or electroporation for transient expression. Chemical-based transfection can
be divided into several types, mainly calcium phosphate [50], liposomes [51], and cationic
polymers [52]. In all cases, a complex of chemical compound and nucleic acid is first
formed and added onto cells. The nucleic acid is taken up by cells via different
mechanisms. Liposomes are small membrane-bounded bodies that resemble a cell
membrane. They can fuse with the cell membrane and deposit DNA. The complex
comprising DNA and cationic polymers is imported into cells by endocytosis. The details
of the calcium phosphate precipitation process are not entirely understood. Electroporation
is another widely used method. It transiently increases the permeability of cell membrane
with short but strong electric pulses, during which time negatively charged DNA diffuses
into the cells. Transfected DNA needs to be transferred into the nucleus for expression,
usually during cell division. Nucleofector technology combines electroporation with
special solution that can directly deliver DNA into the nucleus [53]. In a typical transient
transfection experiment, the introduced genetic material is diluted out as cells proliferate
since the vectors are not replenished in vivo.
1.2.2.2. Stable Cell Line
A stable cell line is one in which an exogenous gene circuit propagates with chromosome
or is integrated into the chromosome. Cells can propagate without losing the introduced
genetic materials, and thus have many advantages over transient expression. The
established stable cell line can be used for long term experiments and be selected for
continuous bioengineering or pharmaceutical production. To create a stable cell line, the
process starts with transient transfection, but in this case, the genetic material either
becomes an episomal plasmid or is integrated into the genomic DNA.
When comparing methods for generating stable cell lines, a few factors are usually
considered to be important [54]. (1) Specificity: Random integration may disrupt
endogenous genetic elements, including important genes and regulatory sequences,
resulting in unpredictable changes in cell phenotype. This can also have a profound impact
on the gene circuit performance, for example, integration in heterochromatin region could
result in silencing of the transgenes. (2) Ease of selection: Some methods may require less
effort to select a clonal cell line with desired properties while other may be time consuming
and labor intensive. (3) Stability: Transgenes should be maintained and be under little
influence from the surrounding genomic sequences.
Non-Integrating Method:
Episomal Vector
The episomal vector or replicating plasmid method is an approach that does not require
genomic integration. Several replicating elements taken from viruses including EBV and
SV40 have been harnessed for keeping a transfected plasmid in an episomal state. In
general, the problem with viral episomal vectors is the requirement of viral regulatory
factors, which are often related to cell transformation, immunogenicity, and cytotoxicity
[45], [54-56]. Alternatively, scaffold/matrix attachment regions (S/MAR) from the
mammalian interferon-y gene cluster have been incorporated into episomal vectors to
replace viral genes. Despite the fact that the vector was shown to be episomal for a short
time without selection [57-59], long term loss of plasmid (5%) [60], integration in the host
chromosome, and rearrangements within the episomal vectors in both viral and non-viral
methods have been reported [61]. Moreover, vector copy number varies considerably
among the same cell lines [57], and a cross different cell lines [61].
Integrating Methods:
Homologous Recombination-based Methods
In mammalian cells, homologous recombination (HR) is used in the repair of double strand
break (DSB) in DNA. Repair machinery, with the guide of homologous sequences, finds
and connects a broken DNA molecule to another DNA molecule via Holliday junctions.
The junctions are resolved by enzymes and the two DNA molecules are linked.
Homologous recombination is used in gene targeting, where integrating donor DNA
contains the similar or identical sequences to the genomic locus where donor is to be
integrated [62]. However, this process is quite inefficient, as the frequency of HR between
donor and target sequences is low [63].
A big improvement in this field was the discovery that recombination could be stimulated
several orders of magnitude by means of a single DSB in genomic DNA [64]. Chimeric
endonuclease proteins have been proven versatile and effective for this purpose. The
synthetic protein links a DNA-binding domain to a DNA-cleavage-domain. The
DNA-binding domain recognizes a specific genomic location, and it brings in
DNA-cleavage domain, the dimer of which cuts DNA. Zinc finger (ZF) assembly was
traditionally used as a DNA-binding domain. Different sequences could be targeted by
evolving and optimizing the ZF assembly [65-67], which is commercially available as
CompoZr integration technology [68]. Recently, the discovery of TAL (transcription
activator-like)proteins provides an alternative to ZF [69-71]. The TAL protein is composed
of tandem repeats signified by their repeat variable di-residues (RVDs). There is a
one-to-one correspondence between RVDs in the repeat domain and the DNA sequence the
protein binds, which constitutes a binding-code [72], [73]. A TAL binding domain can be
efficiently constructed using this binding-code to target a given sequence [39], [74].
Although promising, the HR based integration method often associates with
non-homologous end joining (NHEJ), which could result in endogenous gene disruption
and deletion. Even with the endo-nuclease targeting, random integration is still common
from both HR and NHEJ [67], [69]. The case is even worse in the delivery of complex
mammalian gene circuits as endogenous promoter sequence is often employed in a circuit.
Virus-based Methods
Viruses have evolved naturally to attack their host and delivery their genetic material into
the host cell effectively. Replication incompetent viruses were engineered as vehicles to
carry gene circuits on their genomes and transfer them into host cells. The most widely
used viral vectors are derived from the Adeno-Associated Virus (AAV) Vector [75], and
the Lentivirus vector [76] chosen for their relative simplicity in handling. However,
delivery capacity with these viral vectors is restricted by their viral packaging size, usually
6kb for the AAV and 10kb for the Lentivirus [77]. A bigger concern with viral approach, in
general, is that non-specific incorporation of DNA into the host chromosome (insertional
mutagenesis) can disrupt cellular sequences, leading to undesired effects. Besides, the
expression of virus factors during and after viral infection have implications in
cytotoxicity and cell transformations[5 5].
Recombinase-based Methods
The performance of the methods mentioned above is more or less subject to unpredictable
cellular genomic alternations. Recombinase based methods or more recent
recombinase-mediated cassette exchange (RMCE) approaches have been proposed to
enable non-disruptive insertion of genetic cassettes at pre-characterized genomic locus
[78]. The idea behind these methods is similar to that of recombinase based assembly. Here,
a pair of recombination sites are placed on a genetic circuit to be delivered and on a
pre-characterized genomic target locus (landing pad site) respectively. The landing pad is
inserted into a host cell chromosome prior to delivery. Upon expression of the recombinase
a gene circuit can be inserted in the landing pad, or be exchanged into the landing pad
(RMCE). Cre-LoxP and Flp-FRE systems are traditionally used for this purpose. Unlike
those two, phiC31 catalyzes irreversible integration reaction, and is thus more efficient at
transgene insertion or cassette exchange. In parallel to their benefits, caution is called for
when using these recombinases. Pseudo integration sites for loxP, FRT, and phiC31 have
been identified in the mouse genome. They can mediate recombination between the
degenerate sequences although with lower efficiency [79-81]. Cytotoxicity was also
reported [82] when recombinases were over-expressed. More recently, Mycobactriophage
Bxbl integrase has been shown capable of site-specific integration with higher efficiency
and specificity compared to phiC31 [83], [84], yet more studies need to be done to
elucidate their performance.
1.3. Thesis Organization
This thesis is organized as follows: Experimental materials and methods are listed in
Chapter 2. Chapter 3 describes the flow of the newly proposed method for large genetic
circuit construction and its important features. In addition, results of the experiment are
given and discussed. In Chapter 4 several delivery methods are developed and tested
individually for introducing large genetic circuits into mammalian cells . Additional
experiment on genetic elements, called insulator sequences, are also presented.
Conclusions and suggestions for future improvements are given in Chapter 5.
24
Chapter 2
2. Material and Methods
Molecular Biology
Restriction enzymes I-Scel endonuclease (R0694) and T4 DNA ligase (M0202) were
purchased from New England Biolabs (NEB), MA. AccuPrime Pfx Supermix from
Invitrogen (Life technologies, Carlsbad CA) was used for PCR amplification. Taq
polymerase (M0273) and LongAmp Taq polymerase (M0323S) from NEB were used in
PCR verification of the site specific integration. Enzymes used for Gibson assembly were
purchases from vendors as described in the paper [1]. The E.cloni 1OG (60080) bacteria
strain from Lucigen was used for most cloning experiments except for the pJazz based
system. A BigEasy v2.0 Linear Cloning System (pJazz) (43024, Lucigen Corp.,
Middletown WI) was purchased and used according to its manual. Antibiotic were used
with following concentrations: 100 ug/mL ampicillin, 50ug/ml kanamycin, 25ug/ml
chloramphenicol. Gel extraction was done with a Qiagen QlAquick Gel Extraction Kit.
PCR purification was done using a Qiagen QlAquick PCR Purification Kit. A
NucleoTraPCR from Macherey-Nagel was used for purification in some cases as indicated
in the main text. Miniprep of DNA was accomplished using a Qiagen Qiaprep Spin
Miniprep Kit. Some minipreps were automated on a Qiagen Qiacube using the same
miniprep kit.
Gateway pENTR library
Gateway BP reactions were performed in accordance with the manufacturer's manual (Life
technologies, Carlsbad CA) except for scaling down of the reactants used and reaction
volumes. Briefly, to create the promoter library, promoter sequences of interest were
amplified, digested, and inserted into pENTRL4_Li cut with compatible restriction
enzymes. To create a gene library, genes of interest were amplified with an attB1 site added
(GGGGACAAGTTTGTACAAAAAAGCAGGCTGA) in the forward primer and an
attB2 site added (GGGGACCACTTTGTACAAGAAAGCTGGGTA) in the reverse
primer. 10 fmol of the PCR product was mixed with 5 fmol of pDONR221_P1_P2 and
incubated with lul of BP clonase 11 (11789-020, Life technologies, Carlsbad CA) for 1
hour. 1 ul of the reaction was transformed into ccdB sensitive competent E. coli cells. As an
alternative protocol, gene sequences of interest were amplified, digested, and inserted into
pENTR_Li_L2 cut with compatible restriction enzymes.
Gateway LR reaction
Gateway LR reactions were performed in accordance with the manufacturer's manual (Life
technologies, Carlsbad CA) except for scaling down of the reactants used and reactions'
volumes. Briefly, 5 fmol of each of pENTRL4-Promoter-R1, pENTR_Li-Gene-L2, and
pZDonorSeqn-GTW-Seqn+1 that contains Gateway cassette of pDESTR4_R2 were
mixed and incubated with lul of LR clonase II mix (11971-020, Life technologies,
Carlsbad CA) for 16 hours. 1 ul of the reaction was transformed into ccdB sensitive
competent E. coli cells.
Assembly
* Digestion of Input Vectors
70 fmol of each vector containing basic assembly units were pooled and digested in a total
volume of 20 ul for three hours using 10 units of the restriction enzyme I-SceI (R0694,
NEB Biolabs, MA). Subsequently, this digest was purified using the QIAGEN Qiaquick
PCR purification kit and eluted into 30ul of warm EB buffer.
0 Digestion of the Adapter Vector
210 fmol of the adapter vector required for proper circuit closure was digested in a total
volume of 20 ul with 5 units each of restriction enzymes XbaI and XhoI (R0146, R0145,
NEB Biolabs, MA) for three hours, purified using the QIAGEN Qiaquick PCR purification
kit and eluted into 30 ul of warm EB buffer.
0 Digestion of the Carrier Vector
2100 fmol of the carrier vector was digested in a total volume of 20 ul with 10 units of the
restriction enzyme FseI (R0588, NEB Biolabs, MA) for one hour, purified using the
QIAGEN Qiaquick PCR purification kit and eluted into 30 ul of warm EB buffer.
* One-Step Assembly (Gibson Reaction)
Isothermal Reaction Buffer (ISO) was prepared on ice and stored at -20C: 25% PEG-8000,
500 mM Tris-HCl pH 7.5, 50 mM MgCl2, 50 mM DTT, 1 mM each of each dATP, dCTP,
dGTP, dTTP, and 5 mM NAD. Assembly Master Mix was prepared on ice and stored at
-20C: 320 p1 ISO buffer, 0.64 pl of 10 U/ pl T5 exonuclease (T5E4111K, Epicentre
Biotechnologies, WI), 20 pl of 2 U/pl Phusion polymerase (F-530, NEB Biolabs, MA), 160
p1 of 40 U/pl Taq ligase (M0208, NEB Biolabs, MA), bidistilled water to 1.2 ml [49]. 7
fmol of each part (digested and purified adapter vector, carrier vector and pool of assembly
units) were combined in a 200 ul PCR reaction tube on ice and filled up to 5 ul of the total
volume with bidistilled water. The mix was then added into 15 ul of Assembly Master Mix
and the reaction was incubated at 50C for one hour. 2 ul of this reaction were then
transformed into competent E. coli cells.
* Hierarchical Assembly
BAMs and adapter were assembled into a hierarchical carrier vector pJazz Swing. 70 fmol
of the assembled vector was digested in a total volume of 20 ul for three hours using 10
units of the restriction enzyme I-Scel. Subsequently, this digest was purified using the
QIAGEN Qiaquick PCR purification kit and eluted into 30 ul of warm EB buffer. 7 fmol of
this digest were pooled with other 7fmol BAMs digest, 7 fmol adapter vector, and 7 fmol
carrier vector. A one-step assembly protocol was applied in this mixture.
Microscope Imaging
Images were taken using a Zeiss Axiovert 200M epi-fluorescence microscope equipped
with a 1344x1024 pixel cooled ORCA-ER CCD camera (Hamamatsu Corporation) and a
l0x objective. Fluorescence images were analyzed in Zeiss Axiovision digital image
processing software.
Flow Cytometry Measurement
Flow cytometry measurement was carried out on a BD LSR II in the Koch Institute Flow
Cyctometry Core at MIT. Data was collected in BD FACSDiva software and analyzed in
Flowjo (Tree Star, Inc. Ashland, OR).
Cell Culture
HEK293FT from Invitrogen was cultured according to its handling manual. Chemical
DNA transfection was done using Qiagen SuperFect Transfection Reagent. Nucleofection
was carried out in a 4D-Nucleofector system from Lonza AG. All experiments were done
in accordance with protocols from their original manufacturers. To induce Tet-On
activation, Doxycycline from Clontech was added to culture media at lug/ml.
0 Creation of pCircuit-2 stable cell line
300 ng pCircuit-2, 200 ng pCN and 6 ul Metafectene Pro (Biontex, Germany) were added
to 70 ul of DMEM medium, incubated for 15 min. and added to 400'000 HEK293FT cell in
2 ml of DMEM medium. The supernatant was replaced the next morning and Hygromycin
selection (200ng/ul) was started five days post-transfection and continued for the next 10
days. Subsequently, clonal cell lines were picked and expanded.
0 Creation of Bxbl landing pad cell line
The cell line was created by my colleagues Xavier Duportet, Dr. Patrick Guye, and was
screened by Dr. Patrick Guye and Dr. Liliana Wroblewska. Briefly, a landing pad vector
was integrated into HEK293FT cell genome by using CompoZr integration technology.
The stable cells were selected with Hygromycin.
Chapter 3
3. Rapid Construction Method for Large Genetic Circuit
This Chapter describes the novel construction method developed herein for large genetic
circuits consisting of multiple expression units.
3.1. Design of Complex Gene Circuit
3.1.1. Expression Unit
A complex gene circuit is built upon expression units. Each expression unit (EU) specifies
how a gene will be expressed and regulated. The consortium of these EUs defines the
complete function of a gene circuit. The combination of a promoter and a gene forms an
EU."Promoter" refers to a non-coding sequence that can drive downstream expression. It
may include not only a promoter sequence but also a promoter with a 5'UTR intron that
contains important regulatory elements. Different promoters constitute a promoter library.
Similarly, "gene" refers to a coding sequence or any other sequence that is expressed under
the promoter. For example, cDNA, microRNA, and cDNA with 3' UTR regulatory
elements are all under the name "gene" in this context. Different genes constitute a gene
library and a gene chosen from the gene library can be paired with any promoter chosen
from the promoter library. By specifying the EUs' function and their inter-relationship, a
complex gene circuit is designed. To ensure that the gene circuit design is flexible and
functional, not only do we leave the design flexibility at the EU level, but we also specify
the fundamental structure of assembly so that EUs can be assembled together and behave
reliably in mammalian cells. In this assembly method, an EU is embedded within a Basic
Assembly Module (BAM).
3.1.2. Basic Assembly Module, Input Vector
A BAM consists of a chromatin-control related element (insulator), an EU, and a
polyadenylation signal (polyAs) with a transcription termination sequence (Figure 3-1).
These genetic elements are essential for reliable gene-circuit functions. A mammalian
gene's expression can be affected by its genomic environment [85]. Firstly, inhibitory
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Figure 3-1: Basic assembly module and UNS mis-anneal
(a) A BAM consists of an insulator, an EU, and a polyadenylation signal (PolyAs) with transcription
termination sequence. Unique nucleotide sequences (UNSs) guide BA Ms assembly into a full circuit. (b)
Assembly efficiency is affected by the quality of the UNSs; the annealing of non-complementary UNSs,
and UNSs with other exposed single-stranded DNA results in faulty assembly. Unspecific annealing can
occur in various ways including between different UJNSs, UJNS and the reverse complementary (rc)
UJNSs, UNSs and an insulator (exposed by exonuclease), UNSs and Polyadenylation Signal (exposed by
exonuclease). Because the free leading head of UNSs can serve as a seeding region for unspecific
annealing, even though the entire sequences may not have a high alignment score (Smith-Waterman),
the alignment constraints are applied to the 7bp leading head on both sides of the UNSs.
chromatin can potentially shut down transgene expression regardless of its own regulation.
Secondly, crosstalk from surrounding enhancers can exert additional regulations on
transgene expression. Thirdly, transgene activation may be blocked by methylation. A
chromatin-control insulator is included for reducing or minimizing interference between
adjacent transcriptional units and methylation silencing. In this system, we selected the
chicken DNase-I hypersensitive site 4 (cHS4) from p-globin locus as a chromatin insulator
[86-90]. In addition to insulator, a polyadenylation signal is placed downstream of the EU.
Most eukaryotic newly-made mRNAs are polyadenylated at 3' end during a process
whereby polyadenylation signal is recognized by a protein complex and the mRNA tail is
cleaved and poly(A) is synthesized at the end. The poly(A) tail is important for mRNA
stability. We use a polyadenylation signal sequence taken from a Rabbit betal -globin gene
[91].
Framing the BAM on each side is a homing enzyme I-Scel restriction site and an unique
nucleotide sequence (UNS) inside the I-SceI site. The homing enzyme sites enable cutting
out the BAMs from their circular vectors by I-SceL. Unlike typical restriction enzymes,
I-Scel recognizes a 18bp restriction site. Because it is so long, this site is rarely present in
mammalian promoters and genes. The UNSs on BAMs are exposed in the assembly
process and they anneal only to their complementary UNSs, so that the whole genetic
circuit can be assembled reliably from compatible BAMs in a predetermined fashion.
In the assembly process, a promoter and a gene are recombined to form the EU within the
BAM. The physical vector containing the BAM is called the position vector before the
insertion of a promoter-gene pair and after EU is formed, the vector is called the input
vector as it is the input to the subsequent circuit assembly (Figure 3-4).
3.1.3. Design of Unique Nucleotide Sequences
Unique nucleotide sequences (UNSs) guide BAMs' assembly into a full circuit (Figure
3-1). Unspecific annealing can happen between non-compatible UNSs, UNS and the
reverse complementary (rc) UNSs, UNSs and insulator (exposed by exonuclease), UNSs
and Polyadenylation Signal (exposed by exonuclease). Therefore, it was necessary to
design UNSs such that the probability of any unspecific annealing other than between
complementary UNSs is low enough for assembly of 8 or more BAMs simultaneously.
Computationally, the Smith-Waterman local alignment score was used as a measure for the
annealing probability. The probability of unspecific annealing is proportional to the
Smith-Waterman local alignment score of the involved sequences - the higher the
alignment score, the higher the probability that two sequences will anneal.
procedure Stochastic Local Search for UNS Design
input: Number of UNS, length of UNS, search pool size, set of constraints (C), crossover rate
mutation rate A
output: Set of UNS that satisfy C
S:= 0
P:= initial random pool of candidate UNSs
for I 1 to maxlterations do
for i :=1 to maxTries do
for j := 1 to size(P) do
if P(j) satifsfies all constraints then
add P(j) to S
if S contains enough UNSs then
return S
end if
end if
for k :=1 to size(S) do
AF(k) is increased by the number of alignments fails for UNS(k) E S in current iter
end for
0 := inverse proportional to the # of constraints that candidate E P violate
for k :=1 to size(P) do
select cUl, cU2 E P with probability 0 respectively
ci: new candidates from crossover(cUl, cU2, 3)
add P new candidates from ci by mutating bases with rate X
end for
if P has indentical candidates within P U P then
remove identical candidates from P
add random candidate to fill P
end if
P:= P
end for
end for
remove UNS E S that has maximum AFfor all UNSs E S
end for
return S
end
Figure 3-2: Stochastic local search algorithm for iterative UNSs searching
Because the free leading ends of UNSs can serve as the seeding region for unspecific
annealing, even though the entire sequences may not have high alignment scores,
alignment constraints were applied to the 7bp leading head on both sides of UNSs
In addition to avoiding unspecific annealing, several other constraints needed to be met:
Firstly, it was necessary to ensure that all complementary UNSs annealed easily within a
certain temperature range. This condition was determined by the annealing temperature of
UNSs. Secondly, secondary structure within the UNS had to be minimized. Secondary
structure of UNSs can affect correctness and efficiency of annealing between two
matching sequences and, hence, the efficiency of assembly. The GC content percentage of
an UNS was set to be within a certain range (Table 3-1). Thirdly, the UNS needed to be free
of some restriction sites so as to allow easy modification to the assembly vectors by
restriction cloning. Table 3-1 lists the constraints used in the design of UNS and the
parameters used for UNS searching.
Parameter Constraints Value
Length of UNS 40
Length of UNS head region tested in alignment 7
Smith-Waterman alignment threshold for whole sequence 50
Smith-Waterman alignment threshold for sequence head region 25
Restriction sites Agel, Xbal
Secondary structure dG -5 kcal/mol
Annealing temperature 65C - 75C
GC content percentage 40% - 80%
Crossover rate 0.9
Mutation rate 0.1
Random sequence pool size 10
Table 3-1: Parameters and constraints used for UNS design and searching
A crucial element of this research was the design of a stochastic local search algorithm for
iterative UNSs searching and optimization. In each iteration, the algorithm starts with a
pool of random sequences. Each sequence from the pool is aligned to the UNSs already
found. The best sequence, with alignment scores lower than a threshold, is screened for its
secondary structure, melting temperature, and restriction sites. If it meets all constraints, it
is added as a new UNS to the pool of existing UNSs. The algorithm repeats the process
until a desired number of UNSs are found. If no sequence from the random pool meets all
requirements, a few sequences with better alignment scores are picked. A new search pool
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Figure 3-3: Carrier vector and adapter vector
(a) Carrier vector has Seq 1 -FseI-SeqX and components for replication, selection, and elements specific
for different delivery methods. (b) Adapter vector contains SeqN, SeqX as well as second selection
marker.
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is then generated by recombining and mutating those selected sequences, and by adding
newly generated random sequences, a process similar to a genetic algorithm. Subsequently,
the search procedure repeats. If the iteration number exceeds a maximum, it is assumed
that some of found UNSs are too restrictive for addition of a new sequence. In this case, the
UNS that failed for most alignment-test failures will be removed, and a new search process
started. A complete UNS design algorithm is shown in (Figure 3-2). 13 new UNS were
designed with this algorithm. The quality of the design sequence is measured by the AG
gap, the smallest energy gap between any pair of matching UNSs and mis-matching UNSs
[92-94]. The AG gap for the designed sequence is -32 kcal/mol. In the current
implementation, the first 9 UNSs were chosen and named Seql to Seq8 and SeqX.
3.1.4. Carrier Vector
A carrier vector has three roles: (1) to allow BAMs to assemble into it; (2) to recover the
fully assembled gene circuit; (3) to assist in gene circuit delivery (Figure 3-3). Every
carrier vector has a Seql-FseI-SeqX cassette. FseI is chosen because it is only present once
in the carrier vectors. FseI cuts open the cassette allowing exposure of UNS, Seql and
SeqX. The carrier vector takes in all assembly inputs with Seql and SeqX annealed to the
complementary UNSs on BAMs. Because the assembly reaction produces various
intermediates, the fully assembled circuit needs to be selected and propagated to provide a
large yield. Carrier vectors based on different replication mechanisms have distinct
abilities to recover large gene circuits containing repetitive elements (e. g. chromatin
regulatory elements, and polyadenylation signals on every input vectors). Firstly, the
plasmid copy number affects large DNA molecules' stability [95], [96]. A
high-copy-number plasmid is unsuitable for cloning large DNA fragments or DNA regions
with secondary structure because inter-plasmid recombination is likely to happen, a result
that would lead to loss of intact genetic circuit. On the other hand, a low copy number
plasmid has low yield, meaning that significantly more bacterial culture is required to
produce enough DNA for delivery. Secondly, the supercoiled status of the carrier vector is
important. Plasmid supercoiling can induce secondary structures, bring homologous
sequences close, favoring intra-plasmid sequence deletion and rearrangement [97], [98].
Prophage of coliphage N15 replicates as a linear dsDNA molecule with closed ends
generated by a phage enzyme termed protelomerase (TelN). The linear cloning vector
pJazz based on the phage genome showed improved stability for many types of DNA
sequences, including AT-rich sequences, and sequences with short tandem repeats [97].
This study used carrier vectors based on pBR322 and pJazz.
In addition to differing in replication mechanism and selection markers, carrier vectors
differ in the backbone sequences specific to distinct delivery methods (Table 3-2).
Delivery methods Elements put on carrier vector backbone
Transient transfection No additional sequence
Episomal persistence EBNA/oriP or S/MAR transcription unit
Homologous recombination, e.g. CompoZr Homologous sequences, e.g. AAVS locus
Recombinase based integration, e.g. Bxb 1 Recombination site, e.g. Bxbl attB site
Minicircle, e.g. minicircle mediated by Bxbl Recombination site, e.g. Bxbl attR site
Table 3-2: Carrier vectors contain genetic elements for distinct delivery methods
3.1.5. Adapter Vector
To assemble a full circuit, the UNSs on each BAM need to form a closed loop. An adapter
vector containing the necessary UNSs to form a closed loop is added (Figure 3-4). For
example, in order to construct a genetic circuit with 6 BAMs, an adapter vector which has
Seq7 and SeqX is added, while the carrier vector always contains SeqX-Seql. This adapter
also helps increase the assembly efficiency. It is frequently observed that cut-open carrier
vectors can re-ligate, which causes a significant drop in assembly efficiency. An adapter
that has the second selection marker, e.g. Kanamycin resistance, is used with a second
antibiotic, e.g. kanamycin, preventing the re-ligated carrier vector from propagating.
3.2. Construction Flow
3.2.1. One Step Assembly
A complete genetic circuit construction flow is shown in Figure 3-4.
The Mammalian promoters and the genes of interest are built into Gateway entry vector
libraries and are sequence verified. To construct a full gene circuit, promoters and genes
forming EUs are first picked up from libraries and then recombined into BAMs. The same
promoters or genes can be reused in different promoter-gene pairs in a modular fashion.
The recombination step is usually done in a Gateway LR reaction. As mentioned in
Chapter 1, this is a recombinase based cloning step which does not involve a
mutation-prone process. If the gene circuit to be built contains EUs that have been already
constructed, input vectors harboring those EUs can be reused.
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Figure 3-4: Assembly construction flow
Gene Library
In the second stage of assembly, a particular carrier vector is selected depending on how
the circuit is to be delivered. This flexibility allows quick circuit tests of various delivery
methods. Input vectors are digested with I-SceI to release BAMs. The chosen carrier vector
and adapter are digested, leaving UNSs on the ends. Thereafter, two approaches can be
applied to assemble the whole circuit in a single step. In one implementation, the I-Scel site
residue and exposed UNSs on input vectors are removed by exploiting a special property
of the residue site. The site sequence only contains three different types of nucleotides,
namely C, A, T. Double G are placed between the I-Scel site and the UNS, and when the
I-Scel digested BAMs are subject to T4 exonuclease in presence of only dGTP, 3' ends of
DNA are chewed up to the GG leaving the UNS intact but removing the I-SceI site
completely. After purifying the samples, assembly is carried out in a Gibson reaction (with
non-error correcting polymerase) where UNSs are exposed, joined, and the dsDNA are
repaired [48], [49]. In another implementation, the Gibson reaction is run directly on the
digested inputs. The error-correcting polymerase in Gibson reaction mix can act as an
exonuclease in 3'-5' direction removing the I-Scel residue site.
3.2.2. Hierarchical Assembly
In this research implementation, 7 position vectors were constructed resulting in the ability
to assemble genetic circuits containing up to 7 EUs, corresponding to 14 gateway entry
vectors. One way of going beyond 7 EUs is to construct more position vectors, which allow
assembly of larger constructs in one-pot. While simultaneously combining multiple BAMs
in a single step provides a high value, construction techniques also benefit from
hierarchical assembly protocols that allows nested or multiple levels of construction from
intermediate assemblies.
Hierarchical assembly reuses assembled circuits as inputs to nested assembly. An
assembled circuit can be converted to a large assembly input flanked by SeqI and Seq2. To
facilitate this, one I-Scel site is placed upstream of Seql on the carrier vector and another
I-Scel is placed downstream of Seq2 on the adapter vector (Figure 3-4). The assembled
gene circuit can be readily digested by I-Scel to release the assembled BAMs and be used
as an input filling in the first position in a nested assembly.
3.3. Assembly Efficiency Measurement
The assembly efficiency was measured by determining the ratio of bacterial colonies
containing the correct vector out of the total screened colonies (Figure 3-5). Colonies were
picked randomly and grown for 16 hours. Following the pelleting of the bacteria, the cells
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Figure 3-5: Restriction digestion and PCR analysis of assembled circuit
The assembly efficiency was measured by determining the ratio of bacterial colonies containing the
correct vector out of the total screened colonies. In cases where the restriction bands are too numerous to
distinguish the correct ones from the incorrect ones, the sample was amplified with a set of primers
designed for each BAM. (a) Assembly of 8 BAMs was digested with Xbal. Ethidium bromide stained
gel of 8 minipreps showed the same restriction pattern. (b) Hierarchical assembly of 10 BAMs was
amplified with a set of primers. Expected bands are 2653 and 3564 in lane 1, 3564 and 4757 in lane 2,
3220 and 6562 in lane 3, 5218 and 3218 in lane4, 1509 in lane 5. Hyperladder I lane was duplicated on
the side and adjusted for light and contrast in Photoshop (Adobe System Inc.)
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were lysed and plasmid DNA was extracted. Recovered plasmid DNA was digested, run on
an agarose gel and checked for its restriction pattern. In cases where the restriction bands
were too numerous to distinguish the correct ones from the incorrect ones, the sample was
amplified with a set of primers designed for each BAM. The PCR products were run on an
agarose gel and checked for their size. Correct minipreps were those that produced the
expected restriction mapping pattern.
Using a library of sequence-verified parts, 8 input vectors were constructed. Assemblies
were performed with an increasing number of input vectors to determine the assembly
efficiency in relation to the number of assembled BAMs (proportional to circuit size). It
was found that the addition of T4 exonuclease treatment consistently yielded lower
efficiency. Therefore, the step for I-Scel residue removal was skipped. Gene circuits were
assembled that were up to 43kb in size and composed of 7 EUs with almost 100%
efficiency. The results are summarized in Table 3-3.
Assemblies using the pBR322-based carrier vector exhibited a decrease in efficiency for
larger circuits (large number of parts and large size). It is described in the literature that the
pBR322 backbone does not have the capacity for carrying large inserts (size > 20 kilobases)
in stable fashion. To confirm this, a 25kb pBR322 plasmid was transformed back into
bacteria, but it was not possible to recover any plasmid with the correct restriction pattern.
Several assembled vectors exhibiting incorrect restriction patterns were sequenced. These
errors were rarely due to mismatching UNS, but rather due to annealing of sequences far
upstream or far downstream of UNS. It is possible that the synergetic reaction of T5
exonuclease and error-correcting polymerase might create these joints. In this model, T5
exonuclease chewed up DNA further. Any mismatching annealing between extended
exposed single strands would be an anchor place for the error-correcting polymerase. Its
3'-5' exonuclease activity would remove non-matching single strands and allow the
dsDNA formation to complete. Since the probability for annealing of all complementary
UNSs decreases with increasing number of inputs (BAMs), it is expected that more
assembly failures like this type would happen with a larger circuit.
Next the hierarchical assembly using the linear pJazz-Swing carrier vector was tested. The
above mentioned hierarchical assembly protocol was applied to a correctly assembled gene
circuit in the pJazz-Swing carrier. Briefly, an assembled circuit was digested with I-SceI
and purified using the Qiaquick PCR columns. It was then pooled with the other input
vector, a carrier vector and an adapter as described for the non-hierarchical assembly.
Following addition of the Gibson Assembly Master Mix and incubation for one hour at
Carrier pBR322 pJazz pJazz
vector hierarchical
parts hierarchical #inputs size (bp) size (bp) size(bp)
1-3-X 3 12/12 8488
1-4-X 4 3/3 16652
1-5-X 5 10/12 23695 5/6 31664
1-6-X 6 9/10 25160 5/5 35527
1-7-X 7 5/7 32737 6/6 42280
1-8-X 8 6/10 33709 9/10 44218
(1-4-X) - 5-X 9 2/5 33337 5/5 43829
(1-6-X) - 3-X 9 5/6 38780
(1-6-X) - 4-X 10 5/7 44448
(1-6-X) - 6-X 12 5/10 54048
(1-6-X) - 8-X 14 1/10 61392
Table 3-3: Assembly efficiency
Assembly efficiency measured by the fraction of the number of colonies that have the expected
restriction pattern out of all colonies screened. 1-3-X means that 2 EUs and 1 adapter are assembled.
(1 -6-X) means 5 EUs and I adapter are assembled and the assembled circuit is reused as the first
position in a nested assembly. x/y notates the screening. x: number of colonies that have the expted
restriction patter. y: total number of colonies screened
Figure 3-6: Assembly efficiency versus circuit complexity
Assembly efficiency data from Table 3-3 is plotted against the size and the number of assembled
modules.
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50C, 2 ul were transformed into competent E. coli cells. Colonies were randomly picked
and plasmids were extracted after 16 hours of incubation.
A 61kb circuit consisting of 12 EUs was successfully assembled. From Figure 3-6, it can be
seen that efficiency dropped quickly for hierarchical. In one possible failure mode, the
original backbone from the first assembly is re-ligated to form the original assembled
sample. Although the chance is low, it could be comparable to the probability of having all
complementary UNSs perfectly annealed to their complementary UNSs when a large
number of BAMs are to be assembled. In the hierarchal assembly, products with re-ligated
samples were indeed found. Another probable reason for low large assembly efficiency is
DNA damage during the purification procedure. The larger the circuit, the higher chance it
will break during purification. This view is partly supported by the fact that assembly
efficiency with gel extraction is much worse than with PCR purification which skips gel
electrophoresis. The NucleoTraPCR purification kit, which uses silica beads and supports
a larger sample size than the silica membrane used in PCR purification, was tried, however
use of this kit resulted in more re-ligated samples. Presumably, this is because it has higher
recovery rate for small pieces, such as the carrier backbone from the first assembly, than
the large assembled BAM. If the backbone is not removed, it could lead to more re-ligated
products of the first assembly in the nested assembly.
Chapter 4
4. Delivery Method for Large Genetic Circuit
This chapter describes and evaluates three different methods for introducing large gene
circuits into mammalian cells.
4.1. Transient Transfection
Starting with transient transfection, the goal is to compare the transfection of an assembled
circuit with co-transfection of several plasmids. The test circuit pCircuit-1, shown in
Figure 4-1, consists of both constitutive EUs as well as inducible EU to mimic a real
application circuit. The human elongation factor 1-a (hEF-1a) promoter constitutively
expresses Enhanced Blue Fluorescent Protein (EBFP). The reverse tetracycline
transactivator (rtTA3) and the Enhanced Yellow Fluorescent Protein (EYFP) are
constitutively expressed under another hEF-la promoter. The fluorescent protein
TaqFP635 (mKate) is expressed under a tetracycline response element (TRE) promoter.
When Doxycycline (Dox) is absent, the TRE promoter is inactive and no mKate is
expressed. When Dox is added, rtTA3 binds the TRE promoter, which then drives mKate
expression. The circuit was assembled and transfected into HEK293 cells. In comparison,
the input vectors from which the test circuit was assembled were also co-transfected into
cells.
Transfection of the assembled circuit (AC) and co-transfection of input vectors (CT)
showed different delivery rates. This was determined by the percentage of the cell
population that co-expressed the two constitutive markers, EYFP and EBFP (Figure 4-1).
The CT showed higher transfection rate than the AC: 66.8% versus 39.4%. This suggests
that small plasmids (<9kb) are easier to deliver than a large construct (17kb). To
characterize the cell population that actually received the gene circuit, the cell population
without EYFP nor EBFP expression was removed from the total cell population in the
analysis. The maximum and mean intensity of EYFP, EBFP, and mKate were comparable
for both cases. It is interesting to note that the average intensity of mKate was slightly
higher in the AC than in the CT despite the fact that the average intensity of EYFP in AC
was only half of that in CT. The EYFP was bicistronically expressed with rtTA3, which
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Figure 4-1: Transient transfection of assembled circuit
(a) The test circuit consisted of both constitutive EUs as well as inducible EU. EBFP, rtTA3 and EYFP
are constitutively expressed under hEF-l a promoters. When Dox is added, rtTA3 binds TRE and drives
mKate expression. (b) From left to right: The percentage of cell population that co-expressed the two
constitutive markers, EYFP and EBFP; The maximum and mean intensity of EYFP, EBFP, and mKate;
The strength of the PCA second component. (c) Cell population that has neither EYFP nor EBFP
expression was removed from the total cell population. PCA was calculated on color pairs and its two
components were drawn (red lines) with the length proportional to their strength respectively.
drove expression of mKate from the TRE promoter. This result suggests two possibilities:
(1) the mKate input vector was transfected at much lower efficiency than rtTA3 input
vector in the CT, so that the availability of mKate plasmid was the limiting factor; (2)
rtTA3 was abundant but inducer Dox or VP 16 activation machinery was the limiting factor.
In either case, the AC showed an advantage over the CT in that it achieved a similar output
(mKate) level without placing an extra burden on cells by resorting to over-production of
rtTA3.
Next the correlation between each EU was investigated. It can be seen that each color pair
showed good correlation in both the AC and the CT. However, the AC exhibited less
variance than the CT. Principal component analysis (PCA) analysis was performed on each
color pair. The first and second PCA components are drawn in Figure 4-1 with components'
length proportional to their strength and it was clear that the CT showed larger variance
(the strength of the second PCA component). The strength of the second component
represented heterogeneity of gene expression. The large variance can be attributed to the
stochastic stoichiometry of transfected input vectors in the CT in addition to the stochastic
transcription-translation process.
4.2. Homologous Recombination Integration
Stable cell lines offer many advantages over transient transfected cell lines. The integrating
circuit pCircuit-2 is shown in Figure 4-2. The red fluorescent protein mKate is
constitutively expressed under a hEF-la promoter. Activator rtTA3 coupled with a
Hygromycin resistance (HygroR) are under a constitutive UbC promoter. The activator
rtTA3 is used for TRE promoter induction and HygroR is an antibiotic resistance gene used
for stable cell line selection. TRE promoter drives expression of EGFP upon Doxycycline
induction. Stable cell lines were created using CompoZr integration technology [68].
Briefly, the circuit was assembled into a CompoZr integrating carrier vector that has an
AAVS homologous sequence on its backbone. Integration of the circuit was mediated by
ZF nuclease dimer that targeted AAVS integration site with high specificity.
Stable cell lines were selected with Hygromycin. Microscopy images are shown in Figure
4-2. mKate expression is constitutive and homogeneous. EGFP expression showed a
distinct difference before and after Dox was added, indicating the tightness of TRE
promoter regulation in the integrated assembled circuit. Notice that the EGFP expression is
heterogeneous compared with mKate expression. This could be due to the stochastic nature
of transcription on TRE promoter. One TRE promoter has 7 rtTA3 binding sites. Random
rtTA3 binding events at these 7 sites may lead to the observed heterogeneity [99].
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Figure 4-2: Integrate circuit using homologous recombination and ZF nuclease
(a) pCircuit-2 consists of three EUs. The red fluorescent protein mKate is constitutively expressed under
hEF- I a promoter. Activator rtTA3 coupled with Hygromycin resistance (HygroR) are under constitutive
UbC promoter. Activator rtTA3 is used for the TRE promoter induction and the HygroR is an antibiotic
resistance gene used for stable cell line selection. TRE drives expression of EGFP upon Doxycycline
induction (I ug/ml). The pCircuit-2 was assembled into the CompoZr integrating carrier vector that has
AAVS homologous sequences on its backbone. (b) The pCircuit-2 was integrated into AAVS locus in
HEK293 cells. Stable cell line was selected with Hygromycin. A single colony was expanded. Cells
were split into two dishes. Fluorescent images were taken after one dish of cells was induced with Dox.
No Dox was added to the control dish.
pUbC
To test if stable cell lines could be selected after large circuit integration, a circuit with five
modules and a size of 25kb was constructed, as shown in Figure 4-3. The circuit allowed
Hygromycin selection and has three fluorescent reporters. We assembled the circuit into
the CompoZr integrating carrier vector and integrated the circuit into HEK293FT cells.
Stable cell lines were selected on Hygromycin. Expectedly, the majority of cells expressed
EYFP, which was bicistronically coupled to Hygromycin selection. However, surprisingly
the fraction of cells that were positive for all constitutive color-markers comprised only a
small portion of the total population (Figure 4-3). Non-fluorescent cells were removed
from the analysis and the double-color positive (DCP) fraction was calculated for all
fluorescent cells. This measure captures the imperfection of the circuit for cases where
some EUs are working while others are not. CompoZr integration exhibited a much lower
DCP fraction than transient transfection. This suggests that random integration or partial
integration might be the causes and rules out other factors like the stochastic noise from
transcription and translation. The CompoZR system utilizes HR for vector integration.
Both HR and NHEJ could mediate (1) integration of circuit fragments; (2) random
integration of circuit into silenced genomic loci; (3) both. The physical damage to circuit
DNA during transfection or nucleofection [100] could exacerbate the case. Besides, gene
silencing from methylation and heterochromatin could lead to loss of color expression.
The experimental results suggested that in the case of large gene circuits integration via HR,
it may be difficult to select a stable cell line that contains functioning circuit with just a
single selection marker. The lower the percentage, the more clonal cells need to be
screened for a one that contains a functional circuit in the specified locus. This means that
screening for the presence of EU that is not coupled to any fluorescent marker or selection
marker may prove to be difficult.
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Figure 4-3: Integration of large genetic circuit using HR and ZF nuclease
(a) The AmCyan, mKate, and EYFP are constitutively expressed. EYFP is bicistronically coupled to
Hygromycin Resistance gene. Two inducible EUs are placed between constitutive EUs. (b) Stable cell
lines were selected on Hygromycin. There were 93.2% of total polyclonal cells expressing EYFP. (c) A
large population only expressed either AmCyan or mKate but not both. (d) Statistics of the fraction of
cells expressing two constitutive fluorescent markers (EYFP+EBFP+ for transient transfection (TT) test
and Bxbl integration (Bxbl) test, AmCyan+mKate+ for CompoZr integration test). In the second
column, non-fluorescent cells were removed (EYFP-EBFP- for TT test and Bxbl test, AmCyan-mKate-
for CompoZr integration test). Induction refers to mKate expression upon addition of Dox.
pCircuit-3
103
EYFP
10 105
"I,- W I - . .-M - - - - , RV II
4.3. Bxbl Landing Pad Integration
In order to minimize random integration recombinase Bxbl mediated integration was
tested. A genetic circuit similar to pCircuit-1 was assembled into the Bxb1 integrating
carrier vector instead of the CompoZr integrating carrier vector (Figure 4-4). The carrier
vector contains Bxbl attB site followed by a promoter-less Puromycin resistance (PuroR).
The targeted cell line contains a Bxbl landing pad in the genome. The landing pad has a
constitutive promoter followed by a Bxb 1 attP site and EYFP-2A-HygroR. Once inside the
cell, the Bxbl attB site on the carrier vector recombines with the Bxbl attP site on the
genome, thereby inserting the genetic circuit into the cell genome. PuroR then replaces
EYFP-2A-HygroR and is expressed under the constitutive promoter. A stable line with
successful integration can be selected with Puromycin.
Results showed that the EYFP/EBFP double positive (DP) cell population comprised 87%
of the total population. Out of those DP cells, 92% cells were expressing inducible mKate.
Of importance is that no color was linked to a selection marker (Figure 4-4). This
suggested that clonal cell lines with intact circuit integrated could be easily screened out
with a single selection marker. As for the remaining 13% cell population, gene silencing
from methylation and heterochromatin spreading could account for the color loss.
Non-specific integration and partial integration are also possible causes, which need to be
further tested.
To test the circuit's long-term performance, polyclonal cells were cultured for an additional
3 weeks under Puro selection and then FACS analyzed. The fraction of DP cell population
dropped from 87% to 62% and the mKate induction rate dropped from 92% to 89.2%
(Figure 4-5). It was not tested whether this decrease came from the population overtaken
by the non-DP cells or from long term gene silencing.
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Figure 4-4: Integration of circuit using Bxb1 recombinase and landing pad cell line.
(a) The test circuit is similar to the pCircuit-I except that it was assembled into the Bxb1 integrating
carrier vector. The Bxbl attB site on the carrier vector crossovers with the attP site on the genome. The
Bxbl integrase links half the attB site to half the attP site and does the same thing to another pair of half
attB and attP sites, thereby inserting the circuit into the host genome. (b) Stable cell lines were selected
with Puromycin and induced by Dox.
4.4. More Tests on cHS4
Mammalian gene expression is subject to extensive epigenetic regulation. Chromosomal
position effects and transcription interference are particularly troublesome for transgene
expression. Integrated gene circuits can have highly variable or even silenced expression
due to surrounding heterochromatin spreading along with de novo methylation, a
phenomenon known as chromosomal position-effect [101]. Transgene expression can also
be altered by regulatory elements situated in close proximity, for instance, in adjacent EUs
[88].
The insulator element has two primary activities: (1) enhancer blocking; (2) position-effect
prevention that alleviates repressive histone modification [102], [103]. The most
characterized chromatin insulator is cHS4, which stands for the DNase-I hypersensitive
site, found within the chicken p-globin locus control region (LCR). Many studies support
the finding that much of its insulation activity lies in a 250-bp core fragment and the
insulating activity is boosted when tandem copies of cHS4 cores are used [86], [101], [104],
[105]. The core region has been dissected into 5 footprinted regions (FI-FV). FII and FVI
are CTCF and USFl binding sites. These two insulator proteins can recruit
histone-modifying complexes and can cooperatively mediate the suppression of
transcriptional interference [88], [89], [106]. While CTCF cannot bind to a methylated site,
VEZF1 has been found associated with Fl, FII, and FV and mediated protection from
methylation.
This study was interested in investigating the cHS4 effect on a large integrated genetic
circuit. Specifically, it is desirable to test the effect of insulator directionality and the effect
of a mutated VEZF 1 binding site on the performance of a gene circuit with multiple EUs,
because previous reports showed inconsistency in cHS4 use [101], [104], [106-109]. A test
was designed with three different setups: in between each adjacent EU (Figure 4-5) (1) 2x
cHS4 cores placed in its forward direction (as was used in the previous section); (2) 2x
cHS4 cores placed in its reverse direction; (3) 2x cHS4 cores placed in reverse direction
with a point mutation in the FL site [110] (Genbank Access Number JF330265, AF515846).
Three circuits were assembled using three sets of position vectors. They differed only in
the insulator. The assembled circuits were delivered and integrated into HEK293FT cells
mediated by Bxbl recombinase. Stable cell lines were selected and FACS analyzed (Figure
4-5). The results showed that insulators in the forward direction gave the highest DP
percentage (EYFP+EBFP+), followed by reverse insulators. Insulators in the reverse
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Figure 4-5: Insulator cHS4 test
(a) Three circuits were constructed using three sets of position vectors, which differ in insulator
sequences. Forward: 2x cHS4 cores were placed in the same direction of the EUs. Reverse: 2x cHS4
cores were placed in the opposite direction of the EUs. Reverse mutation: 1x cHS4 and another lx cHS4
core with a mutation in the FI site were placed in the opposite direction of the EUs. A pair of 2x cHS4
cores with a mutation in the FI site flanks inserted circuit on the landing pad. M: a single mutation. (b)
Statistics of the fraction of cell that expressed both constitutive fluorescent markers (EYFP+EBFP+). In
the second column, non-fluorescent cells were removed (EYFP-EBFP-). Induction refers to mKate
expression upon addition of Dox. (c) The ratio of the fraction of EYFP-EBFP+ versus the fraction of
EYFP-EBFP+ in the total polyclonal cell population.
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direction with a mutation in the Fl had only 41.7%. Similarly, the forward cHS4 gave the
highest mKate induction percentage. Note that EYFP+EBFP- fraction is much lower than
EYFP-EBFP+ fraction in all cases, and the forward cHS4 exhibited more severe imbalance
between EYFP and EBFP expression. Interestingly, the EYFP expression unit is the last
one on the circuit, with only reverse cHS4 insulating it from the chromosomal sequence in
all three cases. The results suggest that the directionality affected insulator performance
and forward cHS4 gave best insulation activity. In order to be conclusive about the
directionality effect, further tests are need to rule out the possibility that the integration
quality (partial integration) are different for three cases and the differences may contribute
to the observed effects.
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5. Conclusion and Future Work
The development of DNA construction and delivery methods of large genetic circuits not
only provides valuable tools for investigating biological questions, but also serves as an
experimental foundation for engineering useful synthetic biological systems. Traditional
methods suffer from one or multiple problems. This thesis presents a new experimental
technique to enable rapid assembly and delivery of large mammalian gene circuits. This
method developed herein enables construction of gene circuits in a modular and efficient
manner whereby: (1) EUs are built reliably upon sequence verified libraries; (2) necessary
elements such as insulators and polyadenylation signals are incorporated with the EUs into
BAMs; (3) multiple BAMs are assembled efficiently, either in a one-step reaction or in a
hierarchical process; (4) circuits are embedded into carrier vectors that best suit delivery
mechanisms. This method has become a routine technique in the MIT Weiss laboratory and
over a hundred circuits were reliably and efficiently assembled over the course of a year by
five people. Very large circuits consisting of 11 EUs with sizes up to 61kb were assembled
successfully.
Assembled circuits were delivered into cells in various ways. Transient transfection
showed that when transferred, an assembled circuit was less noisy than co-transfected
circuit components. Bxbl Integration experiments demonstrated that stable cell lines
harboring intact functional circuits could be readily screened. The cell lines exhibited
decent and stable transgene expressions. Results were presented on the effects of insulator
directionality and the FI site mutant. To date, these were the first tests of insulators in the
context of large gene circuit and forward cHS4 was shown to work best.
As a next step to improve assembly efficiency, tests of protocols with a T4 exonuclease
followed by a non-error-correction polymerase treatment are planned. Since annealing
between non-matching DNA sequences is a major cause for efficiency drop and the
error-correcting polymerase can facilitate this non-matching annealing, it is expected that
high efficiency could be maintained for larger constructs when T4 exonuclease and
non-error-correcting polymerase are used.
The pJazz carrier has superior assembly capability, however, as a linear piece of DNA it
cannot be used for Bxbl mediated integration because the crossover of recombination sites
would split a linear piece into two parts. Current work focuses on developing a
circularization method for pJazz in order to use it with Bxbl mediated recombination
delivery. This circularization would not only make pJazz useful for Bxbl integration, but
also remove the prokaryotic backbone sequence that could otherwise stimulate methylation
and gene silencing [111].
It also critical to verify the Bxb1 integration specificity and it is very likely that insulator
performance is dependent on integration quality. Without this information, it would be hard
to be conclusive about the effects of insulator configurations.
Finally, it is also planned to screen for EYFP+EBFP+mKate+ triple positive cell lines from
Bxb1 integration experiments. Those cell lines will be used for a long term test, the result
of which would provide more information on the long term silencing of integrated circuits.
Appendix A
A. Plasmids Construction
pLV_CAG_CN-2A-CN
The cDNA encoding the two zinc finger nucleases for the AAVS 1 locus separated by a 2A
tag (Efficient targeting of expressed and silent genes in human ESCs and iPSCs using
zinc-finger nucleases, Nature Methods 2009) was synthesized (GeneArt, Germany) and
PCR-amplified with attB1/attB2 tags using the primers oPG608b/oPG609b. Upon
gel-extraction, the PCR-product was recombined into a pENTR__LiL2 vector using BP
clonase (Life Technologies, Carlsbad CA), yielding the pENTR_Li_CN-2A-CN_L2
vector. In a next step, pENTRL1_CN-2A-CN_L2 and pENTR_LiCAGL2 were
recombined into pLV R4R2_GTW using the LR clonase II plus (Life Technologies,
Carlsbad CA), resulting in pLVCAGCN-2A-CN.
pGTW4b
The Gateway selection cassette was amplified from pLenti6 (Life technologies, Carlsbad
CA) using the oligos oPG452/453, cut with XhoI and MluI and inserted into
XhoI/MluI-cut pAAVS 1 -CAGGS-eGFP (Efficient targeting of expressed and silent genes
in human ESCs and iPSCs using zinc-finger nucleases, Nature Methods 2009), resulting in
GTW4b.
pGTW4c
The tandem repeated cHS4 core insulators were extracted from pNI-CD (G. Felsenfeld,
NIH, MD) using EcoRI and KpnI and ligated into MfeI/KpnI-cut GTW4b.
pZDonor_Seq1-FseI-SeqX
XbaI-Seql-FseI-SeqX-MfeI was annealed from oligos o-YQ303, o-YQ304 which gave
XbaI and MfeI compatible overhangs. XbaI-Seql-FseI-SeqX-MfeI was inserted into
pGTW4c cut with XbaI/MfeI.
pZDonor-L_ISceI-Seq1-FseI-SeqX
Mfel-PciI was annealed from oligos o-YQ353, o-YQ354, which gave MfeI and PciI
compatible overhangs. It was then inserted into pZDonorISceI-Seql-FseI-SeqX cut with
MfeI/PciI.
pZDonor_ISceI-Seq1-FseI-SeqX
XbaI-ISceI-Seql-FseI was annealed from oligos o-YQ331, o-YQ332 which gave XbaI and
FseI compatible overhangs. XbaI-ISceI-Seql-FseI was inserted into
pZDonorSeql-FseI-SeqX cut with XbaI/FseI.
pZDonor I-Scel L
HindIII-ISceI-XhoI was annealed from oligos o-YQ205, o-YQ206, which gave HindIl
and XhoI compatible overhangs. It was then inserted into pGTW4c cut with XbaI/MfeI.
pZDonor I-Scel R
AgeI-ISceI-XhoI was annealed from oligos o-YQ207, o-YQ208, which gave Agel and
XhoI compatible overhangs. It was then inserted into pZDonor I-Scel L cut with
AgeI/XhoI.
pHLSA-2A-Puro_1-X_HR
The splice acceptor, puromycin gene and polyadenylation sequences were amplified from
pAAVS1-SA-2A-Puro (Efficient targeting of expressed and silent genes in human ESCs
and iPSCs using zinc-finger nucleases, Nature Methods 2009) using oPG880/oPG881,
digested with NheI and ligated into XbaI-cut pGTW4c, creating
pHLSA-2A-Puro_-X_HR.
pHLSA-2A-Bla_1-X_HR
The bleomycin resistance gene was amplified with a splice acceptor and a 2A tag from
pLenti6 using oPG950/oPG953 and then oPG952/oPG953, digested with BglII and XbaI
and ligated into BglII/XbaI-cut pHLSA-2A-PuroI -X_HR.
pJazz-PreBop, pJazz-BeBop
Subsequently we amplified the HLSA-2A-Puro_ -XHR or the
HLSA-2A-Bla_ -XHR cassette from pHL_SA-2A-Puro_1-XHR respectively
pHLSA-2A-Bla_1-X_HR using oPG450f/oPG451, digested it with NotI and cloned it
into the NotI-cut pJazz vector (Lucigen, WI), yielding pJazz-PreBop (Puromycin
resistance) and pJazz-BeBop (Basticidin resistance).
pJazz-Swing
A 304 bp cassette was digested with NheI and FseI from
pZDonor-LIScel-Seql-FseI-SeqX and ligated into the NheI/FseI cut pJazz-PreBop,
yielding pJazz-Swing
pZDonor Position Vectors
cHS4-Gateway selection cassette-rabbit polyadenylation signal was amplified from
pGTW4c with oligos listed in the table below. It was a nested PCR. The first step used the
first set of oligos and the product was used as the template for the second step PCR with the
second set of oligos. The PCR products were digested with Agel/PacI and ligated into
pZDonor I-Scel R cut with AgeI/PacI. The vectors were selection Cm. The vectors were
diluted into 1 Ofmol for Gateway reaction.
pZDonor Position Vectors Oligos
pZDonor 1 -GTW-2 o-YQ209, o-YQ2 11; o-YQ210, o-YQ212
pZDonor 2-GTW-3 o-YQ213, o-YQ215; o-YQ214, o-YQ216
pZDonor 3-GTW-4 o-YQ230, o-YQ240; o-YQ231, o-YQ241
pZDonor 4-GTW-5 o-YQ232, o-YQ242; o-YQ233, o-YQ243
pZDonor 5-GTW-6 o-YQ234, o-YQ244; o-YQ235, o-YQ245
pZDonor 6-GTW-7 o-YQ236, o-YQ246; o-YQ237, o-YQ247
pZDonor 7-GTW-8 o-YQ238, o-YQ248; o-YQ239, o-YQ249
Table_ A-1: Oligos for construction of position vectors
pKan_cHS4-HAR-Kan-SeqX
Kan resistance was amplified from pDONR221 P1 P2 vector (Life Technologies, Carlsbad
CA) with oligos o-YQ313, o-YQ314. pUC origin of replication was amplified with
o-YQ321, o-YQ322. They were digested with XbaI/XhoI and ligated. cHS4-HAR cassette
was digested from pGTW4c with XbaI/SacII and inserted into the ligated vector cut with
XbaI/SacII.
pKancHS4-Seq2-ISceI-HAR-Kan-SeqX
SalI-Seq2-ISceI-EagI was annealed from oligos o-YQ333, o-YQ334, which gave SalI and
EagI compatible overhangs. It was then inserted into pKan_cHS4-HAR-Kan-SeqX cut
with SalI/EagI.
Adapter Vectors
The adapter vectors were constructed by annealing oligos listed in the table below. The
annealed oligos had XbaI and Mfel compatible overhangs. They were inserted into
pKancHS4-Seq2-ISceI-HAR-Kan-SeqX cut with XbaI/MfeI.
Adapter Vectors Oligos
pKanSeq3-cHS4-Seq2-ISceI-HAR-Kan-SeqX o-YQ335, o-YQ336
pKanSeq4-cHS4-Seq2-ISceI-HAR-Kan-SeqX o-YQ337, o-YQ338
pKanSeq5-cHS4-Seq2-ISceI-HAR-Kan-SeqX o-YQ339, o-YQ340
pKanSeq6-cHS4-Seq2-ISceI-HAR-Kan-SeqX o-YQ341, o-YQ342
pKanSeq7-cHS4-Seq2-ISceI-HAR-Kan-SeqX o-YQ349, o-YQ350
pKanSeq8-cHS4-Seq2-ISceI-HAR-Kan-SeqX o-YQ351, o-YQ352
Table_ A-2: Oligos for construction of adapter vectors
Oligos
GTGACGTGGAGGAGAATCCCGGCCCTAGGCTCGAGATGGCCAAGCCTTTGTCT
oPG950 CAAGAAG
GGGAATTCAGATCTGGCAGCGGAGAGGGCAGAGGAAGTCTTCTAACATGCGGT
oPG952 GACGTGGAGGAGAATCC
oPG880 GGGAATTCCTAGCTAGCAAGCTTCTGACCTCTTCTCTTCCTCC
oPG881 GCTCTATGGGTCGACAGTACTAAGCTTGCTAGCTAGGGAATTCCC
GGGAATTCGCGGCCGCGGCCATTACGGCCTGCTTTCTCTGACCAGCATTCTCTC
oPG450f C
oPG45 1f GGGTTCCTGGCTCTGCTCTCCACGGCCGCCTCGGCCGCGGCCGCGAATTCCC
CACCGCTCGAGACAATTGCATCGATGGTACCGTATCGATGTCGACGTTAACGCT
oPG452 AGTG
oPG453 CTCGTTCAGCTTTCTTGTACAAAGTGGTACGCGTGAATTCCCATG
GGGGACAAGTTTGTACAAAAAAGCAGGCTGACTGCCACCATGGCCCCCAAGAA
oPG608b GAAGCGG
oPG609b GAAATCAATTTCTGAGGCGCGCCTACCCAGCTTTCTTGTACAAAGTGGTCCCC
o-YQ205 AGCTTATTACCCTGTTATCCCTAACCGGTCAGGACACCAC
o-YQ206 TCGAGTGGTGTCCTGACCGGTTAGGGATAACAGGGTAATA
o-YQ207 CCGGTCAGGACACCATTAATTAATAGGGATAACAGGGTAATC
o-YQ208 TCGAGATTACCCTGTTATCCCTATTAATTAATGGTGTCCTGA
ATACTTGAACCGGTTTACCGAGCTCTTATTGGTTTTCAAACTTCATTGACTGTGC
o-YQ209 CAAGC
GAGCTCTTATTGGTTTTCAAACTTCATTGACTGTGCCAAGCTTCTGACCTCTTCT
o-YQ210 CTTCC
TAAGTAGATTAATTAAGGATCTTAAAAACATTATACAATACTACAAGCATAAA
o-YQ211 AACGCAC
AACATTATACAATACTACAAGCATAAAAACGCACCAAGCTTAGTACTGTCGAT
o-YQ212 CCGCTGG
ATACTTGAACCGGTGCGTTTTTATGCTTGTAGTATTGTATAATGTTTTTAAGATC
o-YQ213 CAAGC
TTTATGCTTGTAGTATTGTATAATGTTTTTAAGATCCAAGCTTCTGACCTCTTCT
o-YQ214 CTTCC
TAAGTAGATTAATTAAGGCGTATAAAACATCTGGATAAGACGAGAGATTGGGT
o-YQ215 ATTAGAC
ACATCTGGATAAGACGAGAGATTGGGTATTAGACCAAGCTTAGTACTGTCGAT
o-YQ216 CCGCTGG
ATACTTGAACCGGTCTAATACCCAATCTCTCGTCTTATCCAGATGTTTTATACGC
o-YQ230 CAAGC
ACCCAATCTCTCGTCTTATCCAGATGTTTTATACGCCAAGCTTCTGACCTCTTCT
o-YQ231 CTTCC
ATACTTGAACCGGTGAATTCCCTTATGTGAGTGTAAAAGGCAGGCGAGTTTGTC
o-YQ232 CCAAGC
CCCTTATGTGAGTGTAAAAGGCAGGCGAGTTTGTCCCAAGCTTCTGACCTCTTC
o-YQ233 TCTTCC
ATACTTGAACCGGTTGCTTGCAAAAGCAGTAATTGGAAAGCACTCTCAAAGAA
o-YQ234 TCCAAGC
GCAAAAGCAGTAATTGGAAAGCACTCTCAAAGAATCCAAGCTTCTGACCTCTT
o-YQ235 CTCTTCC
ATACTTGAACCGGTAGATAAGTTGATTTAGCCATAAAATATTGTTTCCGTGACC
o-YQ236 CCAAGC
AGTTGATTTAGCCATAAAATATTGTTTCCGTGACCCCAAGCTTCTGACCTCTTCT
o-YQ237 CTTCC
ATACTTGAACCGGTTCTGAGTCACGGCTTCATTGGCATTCCGTACAACGAACGT
o-YQ238 CCAAGC
GTCACGGCTTCATTGGCATTCCGTACAACGAACGTCCAAGCTTCTGACCTCTTC
o-YQ239 TCTTCC
TAAGTAGATTAATTAAGGGACAAACTCGCCTGCCTTTTACACTCACATAAGGG
o-YQ240 AATTCAC
CGCCTGCCTTTTACACTCACATAAGGGAATTCACCAAGCTTAGTACTGTCGATC
o-YQ241 CGCTGG
o-YQ242 TAAGTAGATTAATTAAGGATTCTTTGAGAGTGCTTTCCAATTACTGCTTTTGCA
AGCAAC
AGAGTGCTTTCCAATTACTGCTTTTGCAAGCAACCAAGCTTAGTACTGTCGATC
o-YQ243 CGCTGG
AAACAATATTTTATGGCTAAATCAACTTATCTACCAAGCTTAGTACTGTCGATC
o-YQ245 CGCTGG
TAAGTAGATTAATTAAGGACGTTCGTTGTACGGAATGCCAATGAAGCCGTGAC
o-YQ246 TCAGAAC
TGTACGGAATGCCAATGAAGCCGTGACTCAGAACCAAGCTTAGTACTGTCGAT
o-YQ247 CCGCTGG
TAAGTAGATTAATTAAGGGGATGCATGGTGTTGTTTTACCGCTATAGGCTCTCT
o-YQ248 GAGGAC
GGTGTTGTTTTACCGCTATAGGCTCTCTGAGGACCAAGCTTAGTACTGTCGATC
o-YQ249 CGCTGG
o-YQ313 ATACTTGATCTAGAAATATTCGCGAGACCGCGGGCAGCTCTGGCCCGTGTCTC
TAAGTAGACTCGAGGGTTAGGCGACTGTTATAACTTACCTCTGTAATACTAGTG
o-YQ314 ATACCGTCTGACGCTCAGTGGAACGACG
o-YQ321 TAAGTAGATCTAGAGGTACGCGTATTAATTGCGTTGCGCT
o-YQ322 ATACTTGACTCGAGAGTTACGCGTCGTTCCACTGAGC
CTAGAATTACCCTGTTATCCCTAGGTTTACCGAGCTCTTATTGGTTTTCAAACTT
o-YQ331 CATTGACTGTGCCGGCCGG
CCGGCACAGTCAATGAAGTTTGAAAACCAATAAGAGCTCGGTAAACCTAGGGA
o-YQ332 TAACAGGGTAATT
TCGACGGTGCGTTTTTATGCTTGTAGTATTGTATAATGTTTTTAAGATCCTAGGG
o-YQ333 ATAACAGGGTAATC
GGCCGATTACCCTGTTATCCCTAGGATCTTAAAAACATTATACAATACTACAAG
o-YQ334 CATAAAAACGCACCG
o-YQ335 CTAGAGGTCTAATACCCAATCTCTCGTCTTATCCAGATGTTTTATACGCCC
o-YQ336 AATTGGGCGTATAAAACATCTGGATAAGACGAGAGATTGGGTATTAGACCT
o-YQ337 CTAGAGGTGAATTCCCTTATGTGAGTGTAAAAGGCAGGCGAGTTTGTCCCC
o-YQ338 AATTGGGGACAAACTCGCCTGCCTTTTACACTCACATAAGGGAATTCACCT
o-YQ339 CTAGAGGTTGCTTGCAAAAGCAGTAATTGGAAAGCACTCTCAAAGAATCCC
o-YQ340 AATTGGGATTCTTTGAGAGTGCTTTCCAATTACTGCTTTTGCAAGCAACCT
o-YQ341 CTAGAGGTAGATAAGTTGATTTAGCCATAAAATATTGTTTCCGTGACCCCC
o-YQ342 AATTGGGGGTCACGGAAACAATATTTTATGGCTAAATCAACTTATCTACCT
o-YQ349 CTAGAGGTTCTGAGTCACGGCTTCATTGGCATTCCGTACAACGAACGTCCC
o-YQ350 AATTGGGACGTTCGTTGTACGGAATGCCAATGAAGCCGTGACTCAGAACCT
o-YQ351 CTAGAGGTCCTCAGAGAGCCTATAGCGGTAAAACAACACCATGCATCCCCC
o-YQ352 AATTGGGGGATGCATGGTGTTGTTTTACCGCTATAGGCTCTCTGAGGACCT
o-YQ353 AATTGAGGGGATAACGCAGGAAAGAA
o-YQ354 CATGTTCTTTCCTGCGTTATCCCCTC
Table_ A-3: Oligos used in this work
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